Product Information
METHYLPHENIDATE ER(CD) 30 MG CP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.7946 per EA under NDC 00115173801. Its NADAC has been published 434 times since Jun 13, 2018.
FDA first approved this application on Jul 28, 2016. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115173801
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205105FDA Approved
7/28/2016
TE Code
AB2
On Market Since
9/20/2016
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER(CD) 30 MG CP has been published 434 times since Jun 13, 2018, and over the history we have for it it has declined 45.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.7946 per EA |
|---|---|
| All-time high | $3.3188 (Jun 13, 2018) |
| All-time low | $0.9240 (Jul 17, 2024) |
| 52-week high | $1.9151 |
| 52-week low | $1.7332 |
| Median price | $1.7496 |
| Average price | $1.8379 |
| Largest weekly change | +58.7% (Jun 19, 2024) |
| Weeks tracked | 434 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER(CD) 30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER(CD) 30 MG CP, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.7946 per EA (NDC 00115173801), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE ER(CD) 30 MG CP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER(CD) 30 MG CP has declined 45.9%. It has been tracked across 434 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER(CD) 30 MG CP?
Since Jun 13, 2018, the NADAC for METHYLPHENIDATE ER(CD) 30 MG CP has ranged from a low of $0.9240 (Jul 17, 2024) to a high of $3.3188 (Jun 13, 2018), with a median of $1.7496 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER(CD) 30 MG CP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER(CD) 30 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE ER(CD) 30 MG CP?
METHYLPHENIDATE ER(CD) 30 MG CP (NDC 00115173801) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.